`W Baseline Gd+
`
`months)
`Lesions
`
`
`Koudriavtseva 1997 (Ex. 1119)
`No. 09
`
`Group
`
`0 Lesions on
`Baseline Exam
`
`1
`
`1 Lesions on
`Baseline Exam
`
`2 Lesions on
`Baseline Exam
`
`3Lesions on
`Baseline Exam
`
`1.9
`
`1.9
`
`5.1
`
`
`
`
`
`
`
`
`
`
`‘gbfiwm
`en‘xwimc‘ hams/wash [puke/M4: Mean
`
`
`
`
`
`N
`
`Mean No. New Gd+ Lesions (6
`months) — Mean No. Baseline
`Gd+ Lesions
`
`
`
`
`
`
`1 - 0 = 1
`
`1
`
`1.9 - 1 = 0.9
`
`2
`
`3
`
`
`
`1.9 - 2 = «0.1
`
`5.1 «322.1
`
`
`
`
`
`
`
`
`Group
`
`
`
`
`Mean No. of New Gd+
`Mean No. of New Gd+ Lesions Per
`Lesions Per Scan
`
`
`Scan] Mean No. Baseline Gd+ Lesions
`
`
`0 Lesions on
`Baseline Exam
`
`1
`
`1/0 = Undefined
`
`1 Lesions on
`Baseline Exam
`
`
`
`
`
`
`2 Lesions on
`Baseline Exam
`
`3 Lesions on
`Baseline Exam
`
`1.9
`
`1.9
`
`5.1
`
`1.9/1 = 1.9
`
`1.9/2 = 0.95
`
`5.1/3 = 1.7
`
`
`
`
`
`
`
`
`
`Page 1 0f 1
`
`_
`-...-
`.-
`I.'::E:'i:riE.H;an-.
`2191130196qu? gjg:
`L 1 Lo
`
`
`
`Biogen Exhibit 2220
`Mylan V. Biogen
`IPR 2018-01403
`
`Page 1 of 1
`
`Biogen Exhibit 2220
`Mylan v. Biogen
`IPR 2018-01403
`
`